Skip to main content

Table 3 Perioperative laboratory data of patients undergoing hepatectomy

From: Factors affecting sufentanil consumption for intravenous controlled analgesia after hepatectomy: retrospective analysis

 

All (n = 562)

PCA-NH (n = 428)

PCA-H (n = 134)

P-value

Median, IQR

Preoperative laboratory data

 AST (U/l)

29.50 (21.00, 49.00)

30.00 (21.00, 52.75)

28.00 (21.00, 44.00)

0.204

 ALT (U/l)

26.00 (16.00, 45.00)

27.00 (16.25, 46.00)

25.33 (15.38, 38.00)

0.179

 Alkaline phosphatase (U/l)

109.00 (81.00, 181.50)

110.50 (83.00, 193.25)

106.33 (79.33, 164.00)

0.159

 Albumin (g/l)

38.30 (34.70, 42.43)

38.20 (34.60, 42.18)

39.03 (35.10, 43.60)

0.139

 BUN (mmol/l)

4.89 (3.89, 6.01)

4.79 (3.78, 5.87)

5.18 (4.12, 6.38)

0.008*

 Creatinine (μmol/l)

67.00 (56.00, 80.00)

66.00 (55.00, 80.00)

70.00 (58.63, 82.25)

0.047*

 Platelet count (× 109/l)

190.00 (138.00, 242.00)

193.00 (142.25, 244.50)

177.20 (115.40, 232.00)

0.043*

 Prothrombin time (s)

13.10 (12.60, 13.80)

13.00 (12.60, 13.70)

13.25 (12.59, 14.06)

0.158

Postoperative laboratory data

 AST (U/l)

101.00 (44.00, 209.00)

97.50 (45.00, 211.00)

110.50 (41.00, 208.00)

0.899

 ALT (U/l)

84.50 (37.00, 188.25)

87.00 (37.00, 186.75)

73.33 (30.00, 196.67)

0.531

 Alkaline phosphatase (U/l)

96.00 (67.00, 162.75)

97.50 (69.00, 170.00)

92.33 (63.75, 140.00)

0.145

 Albumin (g/l)

33.10 (29.60, 36.13)

33.10 (29.93, 36.08)

33.04 (28.70, 36.40)

0.520

 BUN (mmol/l)

4.38 (3.41, 5.44)

4.26 (3.37, 5.27)

4.66 (3.63, 5.65)

0.014*

 Creatinine (μmol/l)

66.50 (55.00, 80.00)

66.00 (54.00, 79.75)

67.00 (56.70, 82.89)

0.111

  1. *P value < 0.05 statistically significant, whether it is a high PCA sufentanil dose comparison between the two groups; Mann-Whitney U test; Chi-square test; n(%) = number (percentage); PCA-H High PCA sufentanil dosage, PCA-NH Non high PCA sufentanil dosage